The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive

Su Yu1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;2 Cancer Research Center, Fudan University Shanghai Cancer Center, Shanghai, China

Yang Zhang1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Yunjian Pan1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Chao Cheng1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Yihua Sun1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaCorrespondence[email protected] [email protected]

Haiquan Chen1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;2 Cancer Research Center, Fudan University Shanghai Cancer Center, Shanghai, China;3 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;4 Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaCorrespondence[email protected] [email protected]

The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date